Hinova Pharmaceuticals Management
Management criteria checks 3/4
Hinova Pharmaceuticals' CEO is Yuanwei Chen, appointed in Sep 2020, has a tenure of 4.17 years. directly owns 13.26% of the company’s shares, worth CN¥472.90M. The average tenure of the management team and the board of directors is 4.2 years and 4.2 years respectively.
Key information
Yuanwei Chen
Chief executive officer
CN¥3.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.2yrs |
| CEO ownership | 13.3% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.2yrs |
Recent management updates
CEO
Yuanwei Chen (61 yo)
4.2yrs
Tenure
CN¥3,177,400
Compensation
Dr. Yuanwei Chen is Chairman of the Board and General Manager of Hinova Pharmaceuticals Inc. since September 21, 2020. Dr. Chen has been General Manager of China Gateway Pharma Products (ChengDu) and Vice...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & General Manager | 4.2yrs | CN¥3.18m | 13.26% CN¥ 472.9m | |
| VP of Operations | 4.2yrs | CN¥1.41m | no data | |
| CTO & Director | 4.2yrs | CN¥2.40m | 1.58% CN¥ 56.4m | |
| Accounting Supervisor | no data | no data | no data | |
| Executive Vice President of Commercial | less than a year | no data | no data |
4.2yrs
Average Tenure
61yo
Average Age
Experienced Management: 688302's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & General Manager | 4.2yrs | CN¥3.18m | 13.26% CN¥ 472.9m | |
| VP of Operations | 1.2yrs | CN¥1.41m | no data | |
| CTO & Director | 4.2yrs | CN¥2.40m | 1.58% CN¥ 56.4m | |
| Director | 4.2yrs | CN¥745.20k | 3.87% CN¥ 137.9m | |
| Independent Director | 4.2yrs | CN¥180.00k | no data | |
| Supervisor | 1.2yrs | no data | no data |
4.2yrs
Average Tenure
57.5yo
Average Age
Experienced Board: 688302's board of directors are considered experienced (4.2 years average tenure).